CSIMarket
 


Mirati Therapeutics Inc   (MRTX)
Other Ticker:  
 


Mirati Therapeutics Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



MRTX Net Cash Flow Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change 201.97 % 155.32 % 910.86 % 212.37 % -92.44 %
Seq. Revenue Change 19.8 % 91.01 % 667.34 % -82.8 % 1.29 %
Revenue In Millions $16.40 $13.69 $7.17 $0.93 $5.43
Net Cash Flow Margin - -818.55 % 93 % -6807.6 % -
Net Cash Flow Margin Total Ranking # 87 # # 459 # # 139
Net Cash Flow In Millions $128.85 $-112.06 $6.67 $-63.58 $33.24
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2023 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 785.68 %, below company's average Net Cash Flow Margin.

Observing third quarter 2023 results within Major Pharmaceutical Preparations industry 27 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 87.

MRTX's Net Cash Flow Margin third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 50
Overall # 88

Net Cash Flow Margin Statistics
High Average Low
59164.79 % 25120.53 % 93 %
(Mar 31 2020)   (Mar 31 2023)




Other Net Cash Flow Margin Profitability Ratios
MRTX's Cumulative Net Cash Flow Margin
Major Pharmaceutical Preparations Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
MRTX's Net Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for MRTX's Competitors
Net Cash Flow Margin Profit Margin for Mirati Therapeutics Inc 's Suppliers
Net Cash Flow Margin Profit Margin for MRTX's Customers

You may also want to know
MRTX's Annual Growth Rates MRTX's Profitability Ratios MRTX's Asset Turnover Ratio MRTX's Dividend Growth
MRTX's Roe MRTX's Valuation Ratios MRTX's Financial Strength Ratios MRTX's Net Cash Flow Growth
MRTX's Roa MRTX's Inventory Turnover Ratio MRTX's Growth Rates MRTX's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Net Cash Flow MarginSep 30 2023 MRQ Net Cash FlowSep 30 2023 MRQ Revenue
Avalo Therapeutics Inc   1,635.17 %$ 3.859 $ 0.236 
Immunome Inc  1,296.41 %$ 46.217 $ 3.565 
Merus N v   1,275.81 %$ 140.760 $ 11.033 
Aditxt Inc   1,249.46 %$ 1.555 $ 0.124 
Northwest Biotherapeutics inc  1,150.99 %$ 4.673 $ 0.406 
Sage Therapeutics Inc   1,005.01 %$ 27.296 $ 2.716 
Verrica Pharmaceuticals Inc   999.93 %$ 29.168 $ 2.917 
Comera Life Sciences Holdings Inc   947.52 %$ 1.292 $ 0.136 
Tff Pharmaceuticals Inc   878.67 %$ 2.063 $ 0.235 
Mirati Therapeutics Inc   785.68 %$ 128.852 $ 16.400 
Mersana Therapeutics Inc   747.61 %$ 57.551 $ 7.698 
Bioadaptives Inc   715.39 %$ 0.112 $ 0.016 
Ideaya Biosciences Inc   609.69 %$ 49.007 $ 8.038 
Petros Pharmaceuticals inc   576.23 %$ 9.650 $ 1.675 
Urogen Pharma Ltd   484.15 %$ 99.179 $ 20.485 
Igc Pharma Inc   447.77 %$ 1.303 $ 0.291 
Hcw Biologics Inc   442.13 %$ 3.772 $ 0.853 
Cervomed Inc   414.75 %$ 6.331 $ 1.526 
Durect Corp  414.28 %$ 7.225 $ 1.744 
Regen Biopharma Inc  380.36 %$ 0.120 $ 0.032 
Ocular Therapeutix Inc   291.39 %$ 43.944 $ 15.081 
Verve Therapeutics Inc   265.58 %$ 8.278 $ 3.117 
Xoma Corporation  244.22 %$ 2.027 $ 0.830 
Vbi Vaccines Inc  220.62 %$ 14.614 $ 6.624 
Travere Therapeutics Inc   197.79 %$ 73.370 $ 37.095 
Carisma Therapeutics Inc   177.14 %$ 6.779 $ 3.827 
Marinus Pharmaceuticals Inc   172.39 %$ 12.650 $ 7.338 
Molecular Templates inc   159.79 %$ 10.859 $ 6.796 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com